ERBB2 and breast cancer: In conclusion, by training a predictive model with only the few patients analysed here, we could show that the differences in tumour-induced kinome activity of circulating neutrophils could have the potential to distinguish between EBC and benign lesions and it could detect the presence of HER-2 mutation in breast cancer.